Please login to the form below

heart attack patients

This page shows the latest heart attack patients news and features for those working in and with pharma, biotech and healthcare.

NHS could save almost £7bn through its own resources

It’s important for all stakeholders that we take every opportunity to rapidly adopt tests which show cost savings and benefit to patients. ... It found that using the high sensitivity cardiac troponin test to diagnose or rule out heart attack in

Latest news

Daily Brief: Amgen offers Repatha deals in Europe, will Persephone slash Herceptin use?

Amgen’s FOURIER reduced heart attack risks by 27%, stroke risks by 21% and coronary revascularisations by 22%, but didn't provide a mortality benefit. ... Herceptin, which could reduce their risk of heart damage while making significant cost-savings
CV data sets up Novartis' Ilaris for blockbuster sales

with a prior heart attack and inflammatory atherosclerosis when added to standard therapy. ... Novartis' chief medical officer Vas Narasimhan is hopeful. "Despite current treatment, about 25% of heart attack survivors will have another cardiovascular
New outcomes data could unlock Repatha's potential, says Amgen

In the four-year FOURIER trial - which involved 27, 500 patients - the drug significantly reduced the risk of heart attack, stroke and death in patients with heart disease in patients with ... The findings back up an earlier, smaller study ( GLAGOV),
Novartis boosts cardiovascular pipeline with $1bn Ionis deal

The agreement covers drugs designed to reduce two well-characterised factors - lipoprotein(a) and apolipoprotein CIII - that elevate the risk of serious complications such as heart attack and stroke in patients ... Aside from the new additions, Novartis
Bayer helps bankroll new stem cell company BlueRock

of its early projects will be to explore the use of PSCs to regenerate heart muscle in patients who have had a heart attack. ... regeneration in heart attack and heart failure patients.

More from news
Approximately 1 fully matching, plus 52 partially matching documents found.

Latest Intelligence

Proving real-world value

Insights reach R&D that ordinarily take years; beta-blockers, for example, found expanded use to control hypertension only after retrospective analysis of four decades of use in heart attack patients.”. ... We create thousands of patient leaflets

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

Understanding the "Big Picture"

In this case, of the male patients with ACS, 27% experienced angina and 73% experienced a heart attack. ... This quickly demonstrates that the majority of male patients who experience a heart attack will be found within the non ST-elevated heart attack

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Senior Project Manager - Medical Writing: Great salary and bebefits

Client Services Director – Healthcare Advertising - London: Neg

Head of Market Access - International - Based Cambridge: Excellent Basic, Bonus and Flex Benefits

Account Manager: £40, 000 - £45, 000 benefits

Senior Account Manager: Competitive salary commensurate with experience

Account Director, Medical Communications: C£50 – 65, 000 benefits and bonus

Senior Medical Writer, Healthcare Advertising Agency: £45, 000 – £50, 000

Home based, Chief Medical Writer, Medical Communications: Excellent package

Home based, Editorial Team Leader, Medical Communications: Excellent package

Home based, Senior Medical Writer, Medical Communications: Excellent package

Scientific Communications Director - Oncology – In House Pharma ...: Neg

Home based, Principal Medical Writer, Medical Communications: Excellent package

Delivery Manager/ Head of Delivery – Executive Search: Neg

Account Manager, Medical Communications and Marketing: £30, 000 – £40, 000 benefits and bonus

Business Unit Head, Medical Communications, London: Excellent package

Healthcare PR Director: £100, 000 – £120, 000 benefits

Editorial Director – Medical Education (MedComms): Neg

Account Director, Consumer Healthcare PR, Global PR agency: £50, 000 – £58, 000

Strategic Planner, Healthcare Advertising: £47, 000 – £53, 000

Client Services Director - Med Comms: Great salary and bebefits

Principal Medical Writer / Editorial Director – Medical Communic...: £60, 000 - £80, 000

Subscribe to our email news alerts

PMHub

Add my company

3 Monkeys Zeno

3 Monkeys Zeno is an award winning global creative communications consultancy – home to a collective of creative and strategic...

Latest intelligence

Developing advocacy in the pharmaceutical industry.: The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?: Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?: The modern approach to B2B sales is data-driven, and enabled by digital tools....